Table 1.
Test name | Samples | Key references | Method | Genes No. | Genes |
Oncotype DX | FFPE tumor tissue | [31,32] | QRT-PCR | 16 + 5 | MKI67, AURKA, BIRC5, CCNB1, MYBL2, ERBB2, GRB7, ESR1, PGR, BCL2, SCUBE2, MMP11, CTSL2, GSTM1, CD68, BAG1 (+ ref genes ACTB, GAPDH, RPLPO, GUS, TFRC) |
MammaPrint | Fresh or freshly frozen breast cancer tissue or FFPE tissue | [38-40] | DNA microarray | 70 | AA555029_RC, ALDH4A1, AP2B1, AYTL2, BBC3, C16orf61, C20orf46, C9orf30, CCNE2, CDC42BPA, CDCA7, CENPA, COL4A2, DCK, DIAPH3, DTL, EBF4, ECT2, EGLN1, ESM1, EXT1, FGF18, FLT1, GMPS, GNAZ, GPR126, GPR180, GSTM3, HRASLS, IGFBP5, JHDM1D, KNTC2, LGP2, LIN9, LOC100131053,LOC100288906, LOC730018, MCM6, MELK, MMP9, MS4 A7, MTDH, NMU, NUSAP1, ORC6L, OXCT1, PALM2, PECI, PITRM1, PRC1, QSCN6L1, RAB6B, RASSF7, RECQL5, RFC4, RTN4RL1, RUNDC1, SCUBE2, SERF1A, SLC2A3, STK32B, TGFB3,TSPYL5, UCHL5, WISP1, ZNF533 |
Endopredict | FFPE tumor tissue | [41,42] | QRT-PCR | 8 + 4 | BIRC5, UBE2C, DHCR7, RBBP8, IL6ST, AZGP1, MGP, STC2 (+ ref genes CALM1, OAZ1, RPL37A, HBB) |
Prosigna (based on PAM50) | FFPE tumor tissue | [33-37] | Nanostring | 50 + 8 | MIA, SFRP1, KRT14, KRT17, KRT5, FGFR4, GRB7, ERBB2, BAG1, MDM2, ACTR3B, BLVRA, CXXC5, TMEM45B, MMP11, FOXC1, EGFR, CDH3, PHGDH, MYC, CCNE1, CDCA1, CDC20, KIF2C, TYMS, KNTC2, UBE2T, MELK,PTTG1, CCNB1, CDC6, MYBL2, BIRC5, CENPF, EXO1, ORC6L, ANLN, UBE2C, RRM2, MKI67, CEP55, PGR, NAT1, SLC39A6, BCL2, ESR1, MAPT, GPR160, MLPH, FOXA1 (+ 8 ref genes) |
FFPE: Formalin-fixed paraffin-embedded; qRT-PCR: Quantitative reverse transcriptase-PCR.